多肽类药物结构稳定性的研究进展

38020071025ChinMedBiotechnol,October2007,Vol.2,No.5··4[1]Roscic[2]polyethyleneglycolPEG10000PEGPEGPEG-IL-2[3]PEG-[4]2006Pan[5]PEG-1GLP-1CGLP-1Ligeti[6]nociceptinNZobel[7]50L-D-L-Chen[8]D-L-αD-Boeglin[9]Ac-His-D-Phe-Arg-TrpCTrpD'Ursi[10]Ac-Trp-Gln-Asp-Trp-Val-Gly-Trp-IleTrp-richNCSup-35Gly-Asn-Asn-Gln-Gln-Asn-TyrN[11][e-mail]2007-07-1720071025ChinMedBiotechnol,October2007,Vol.2,No.5381Cys-Phe-D-Trp-Lys-Thr-CysNCD-PheThr[12]NC[13]30--αHSA-IFN-αIFN-α18[14]HASIFN-αGGGGS[15]HSA-CD4CD4140[16]DNAPep3Ferre[17]LysPheTrpValPep3[18]NC[19][20]Arg-Gly-Aspdiazaethyleneglycol[21]Arg-Gly-Asp-Val-TyrK562Siemion[22]Cys[23][24][25-26][27-29][30]H-Tyr-c[D-Cys-Phe-Cys]NH2H-Tyr-c[D-Cys-Phe-D-Cys]NH2µδ-CH2-CH2--CH=CH-[31]Tamilarasu[32][1]ZhuLP.ProteinglycosylationandBcellimmunity.ShanghaiJImmunol,2001,21(4):193-194.(inChinese).B.,2001,21(4):193-194.[2]RoscićM,HorvatS.Transformationsofbioactivepeptidesinthepresenceofsugars-CharacterizationandstabilitystudiesoftheadductsgeneratedviatheMaillardreaction.BioorgMedChem,2006,14(14):4933-4943.[3]GoodsonRJ,KatreNV.Site-directedPEGylationofrecombinant38220071025ChinMedBiotechnol,October2007,Vol.2,No.5interleukin-2atitsglycosylationsite.Biotechnology,1990,8(4):343-346.[4]YuAP,JiangZH,ZhongGS,etal.IsolationofPEGylatedhirudinandanalysisonit'sactivity.PharmBiotechnol,2004,11(5):302-305.(inChinese),,,..,2004,11(5):302-305.[5]PanCQ,BuxtonJM,YungSL,etal.DesignofalongactingpeptidefFunctioningasbothaglucagon-likepeptide-1receptoragonistandaglucagonreceptorantagonist.JBiolChem,2006,281(18):12506-12515.[6]LigetiM,BöszeS,CsámpaiA,etal.Synthesisofenzymaticallyresistantnociceptin-relatedpeptidescontainingacarbamicacidresidue.JPeptSci,2006,12(7):481-490.[7]ZobelK,KoehlerMF,BeresiniMH,etal.Phosphateesterserumalbuminaffinitytagsgreatlyimprovepeptidehalf-lifeinvivo.BioorgMedChemLett,2003,13(9):1513-1515.[8]ChenY,VasilAI,RehaumeL,etal.Comparisonofbiophysicalandbiologicpropertiesofalpha-helicalenantiomericantimicrobialpeptides.ChemBiolDrugDes,2006,67(2):162-173.[9]BoeglinD,XiangZ,SorensonNB,etal.Aza-scanningofthepotentmelanocortinreceptoragonistAc-His-d-Phe-Arg-Trp-NH.ChemBiolDrugDes,2006,67(4):275-283.[10]D'UrsiAM,GiannecchiniS,EspositoC,etal.Developmentofantiviralfusioninhibitors:shortmodifiedpeptidesderivedfromthetransmembraneglycoproteinoffelineimmunodeficiencyvirus.Chembiochem,2006,7(5):774-779.[11]ZhengJ,MaB,TsaiCJ,etal.Structuralstabilityanddynamicsofanamyloid-formingpeptideGNNQQNYfromtheyeastprionsup-35.BiophysJ,2006,91(3):824-833.[12]PlessJ.Thehistoryofsomatostatinanalogs.JEndocrinolInvest,2005,28(11Suppl):1-4.[13]O'FagainC.Enzymestabilization:recentexperimentalprogress.EnzymeMicrobTechnol,2003,33(2):137-149.[14]OsbornBL,OlsenHS,NardelliB,etal.Pharmacokineticandpharmacodynamicstudiesofahumanserumalbumin-interferon-alphafusionproteinincynomolgusmonkeys.JPharmacolExpTher,2002,303(2):540-548.[15]ChangSH,GongX,YangZY,etal.Expressioninpichiapastorisandpropertiesofhumanserumalbumin-interferonα2bchimera.ChinJBiotechnol,2006,22(2):173-179.(inChinese),,,.α2b.,2006,22(2):173-179.[16]YehP,LandaisD,LemaitreM,etal.Designofyeast-secretedalbuminderivativesforhumantherapy:biologicalandantiviralpropertiesofaserumalbumin-CD4geneticconjugate.ProcNatlAcadSciUSA,1992,89(5):1904-1908.[17]FerreR,BadosaE,FeliuL,etal.Inhibitionofplant-pathogenicbacteriabyshortsyntheticcecropinA-melittinhybridpeptides.ApplEnvironMicrobiol,2006,72(5):3302-3308.[18]AnishettyS,AnishettyR,PennathurG.Understandingmutationsandproteinstabilitythroughtripeptides.FEBSLett,2006,580(8):2071-2080.[19]Bogdanowich-KnippSJ,JoisDS,SiahaanTJ.Theeffectofconformationonthesolutionstabilityoflinearvs.cyclicRGDpeptides.JPeptRes,1999,53(5):523-529.[20]ChengS,CraigWS,MullenD,etal.DesignandsynthesisofnovelcyclicRGD-containingpeptidesashighlypotentandselectiveintegrinalphaIIbbeta3antagonists.JMedChem,1994,37(1):1-8.[21]MamadouAS,AnnieM,FredericL,etal.SynthesisofRGDamphiphiliccyclicpeptideasfibrinogenorfibronectinantagonist.LettPeptSci,1997,4:455-461.[22]SiemionIZ,GawlowskaM,KrajewskiK,etal.AnalogsofRGDVYandGRGDpeptidesinhibitMycobacteriumkansasiiphagocytosis.Peptides,2003,24(8):1109-1115.[23]GilonC,HalleD,ChorevM,etal.Backbonecyclization:anewmethodforconferringconformationalconstraintonpeptides.Biopolymers,1991,31(6):745-750.[24]BourneGT,GoldingSW,McGearyRP,etal.Thedevelopmentandapplicationofanovelsafety-catchlinkerforBOC-basedassemblyoflibrariesofcyclicpeptides.JOrgChem,2001,66(23):7706-7713.[25]HuangXY,WangT,XiaCQ,etal.Synthesisofnoveldisulfidebond-bearingcyclopeptides.ChinJOrgChem,2004,24(12):1629-1632.(inChinse),,,..,2004,24(12):1629-1632.[26]RanganathanD,HaridasV,KarleIL.Cystinophanes,anovelfamilyofaromatic-bridgedcystinecyclicpeptides:synthesis,crystalstructure,molecularrecognition,andconformationalstudies.JAmChemSoc,1998,120(12):2695-2702.[27]ShrederK,ZhangL,DangT,etal.Synthesisandbiologicalactivityofanovelmethylamine-bridgedenkephalinanalogue(MABE):anewroutetocyclicpeptidesandpeptidomimetics.JMedChem,1998,41(14):2631-2635.[28]HanQW,ZhunXQ,H